Davita (DVA) & Concord Medical Services (CCM) Head-To-Head Review

Concord Medical Services (NYSE: CCM) and Davita (NYSE:DVA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.


This table compares Concord Medical Services and Davita’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Concord Medical Services N/A N/A N/A
Davita 4.65% 12.86% 3.43%

Analyst Ratings

This is a summary of current recommendations and price targets for Concord Medical Services and Davita, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concord Medical Services 0 0 0 0 N/A
Davita 1 4 4 2 2.64

Davita has a consensus target price of $79.00, indicating a potential upside of 12.81%. Given Davita’s higher probable upside, analysts clearly believe Davita is more favorable than Concord Medical Services.

Institutional & Insider Ownership

1.8% of Concord Medical Services shares are owned by institutional investors. Comparatively, 85.8% of Davita shares are owned by institutional investors. 2.0% of Davita shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Concord Medical Services and Davita’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Concord Medical Services $65.54 million 1.95 -$37.71 million N/A N/A
Davita $10.88 billion 1.17 $663.61 million $4.75 14.74

Davita has higher revenue and earnings than Concord Medical Services.

Volatility and Risk

Concord Medical Services has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Davita has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500.


Davita beats Concord Medical Services on 11 of the 12 factors compared between the two stocks.

About Concord Medical Services

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company’s cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.

About Davita

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply